In the previous study of Aye Thant et al., they showed that treatment of NOM1 ovarian cancer cells with fibronectin 1 (FN1) stimulated matrix metalloproteinase (MMP)-9 secretion activated the invasiveness of cells via the FAK/Ras signaling pathway [45,46]. Here, MMP9 is linked to ovarian carcinoma.